blau_bg03
logo03
Home
amt
Home

 

 

Latest news

apoplex medical technologies @ Medica 2008 in Düsseldorf.
Visit us at booth D67 in hall 9 @ the booth from
Geratherm Medical AG.

SRA is awarded with innovation price of KKH

20071025_1SRA at the first german stroke congress

SRA at MEDICA 2007
 

 

 

 

Apoplex medical technologies mission is

  • Perform educational work against the myth of the unexpected with stroke
  • Develop an easy to use tool for prevention and
  • Reach its world wide accessibility
  • To provide people at risk with more security at low effort
  • To provide doctors and clinics with an appropriate procedure in order to
  • Reduce the economical burden of the health systems and last but not least to

Maintain health and quality of life for every body

 

Stroke can be prevented

Atrial fibrillation is the most dangerous risk factor for stroke. In Germany 40.000 patients per year have a stroke caused by atrial fibrillation. In epidemiological studies, 1/3 of the patients with atrial fibrillation were not diagnosed before. In ¼ of the strokes caused by atrial fibrillation it was only diagnosed after the stroke.

There is a therapy to reduce the risk for stroke significantly, an efficient blood anticoagulation. But for that, atrial fibrillation must be diagnosed. But first atrial fibrillation must be diagnosed in time.

30% of the patients experience in the beginning the so called paroxysmal atrial fibrillation with mostly asymptomatic fibrillation episodes. Hence, to detect atrial fibrillation, especially paroxysmal atrial fibrillation, is the challenge.

apoplex medical technologies has the solution as well as for primary and for secondary prevention with it’s stroke risk analysis (SRA).

Home
blau_bg03